Abstract
Bromocriptine lowers plasma ACTH levels in patients with pituitary-dependent Cushing’s syndrome. It seemed possible that the drug would also be effective in patients who had been adrenalectomised for the disease. The effect of 5.0 mg of bromocriptine on plasma ACTH and prolactin levels in 13 patients, bilaterally adrenalectomised for pituitary-dependent Cushing’s syndrome, was therefore studied. In only one patient was a fall in plasma ACTH observed. This may be of doubtful significance since marked spontaneous fluctuation in plasma ACTH levels were found in the five patients tested. Bromocriptine lowered the plasma prolactin in all of the. patients, including two with hyperprolactinaemia.
This is a preview of subscription content, log in via an institution to check access.
References
Lamberts S.W., Birkenhäger J.C. Effect of bromocriptine in pituitary-dependent Cushing’s Syndrome. J. Endocrinol. 70: 315, 1976.
Kennedy A.L., Montgomery D.A.D. Bromocriptine for Cushing’s disease Br. Med. J. 1: 1083, 1977.
Cook D.M., Kendall J.W., Allen J.P., Lagerquist L.G. Clin. Endocrinol. (Oxf) 5: 303, 1976.
Turkington R.W. J. Clin. Endocrinol. Metab. 34: 159, 1972.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Mullane, N., Walker, B., Jefferson, J. et al. Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing’s syndrome. J Endocrinol Invest 1, 355–357 (1978). https://doi.org/10.1007/BF03350982
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350982